title: Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
abstract: Oncolytic herpes simplex virus (oHSV) vectors have shown promise in the treatment of patients with recurrent brain tumors although few complete responses have accrued. Impediments to effective therapy include limited vector distribution on delivery, a consequence of injected virion particle trapping in the tumor extracellular matrix (ECM). To enhance virus delivery and spread, we investigated the use of the matrix metalloproteinase-9 (MMP-9) as a means to degrade collagen type IV, a major component of the ECM and basement membranes of gliomas that is absent in normal brain tissue. SK-N-AS neuroblastoma cells were transduced for constitutive, elevated expression of MMP-9, which did not enhance tumor cell migration in vitro or tumor progression in a murine xenograft brain tumor model. MMP-9 expression improved the distribution and infection of oHSV vectors in spheroid model in vitro. Furthermore, MMP9 induced a vector infection over larger areas of brain tumors in vivo. These results suggest that vector delivery and distribution in vivo can be improved by compromising the ECM, potentially enhancing oncolytic efficacy.
authors.affiliation: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
authors.forename: C-S
authors.initials: CS
authors.lastname: Hong
authors.forename: W
authors.initials: W
authors.lastname: Fellows
authors.forename: A
authors.initials: A
authors.lastname: Niranjan
authors.forename: S
authors.initials: S
authors.lastname: Alber
authors.forename: S
authors.initials: S
authors.lastname: Watkins
authors.forename: J B
authors.initials: JB
authors.lastname: Cohen
authors.forename: J C
authors.initials: JC
authors.lastname: Glorioso
authors.forename: P
authors.initials: P
authors.lastname: Grandi
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000201:enzymology / Q000628:therapy*; D045744:Cell Line, Tumor; D002465:Cell Movement; D005109:Extracellular Matrix / Q000378:metabolism; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D050130:Oncolytic Virotherapy / Q000379:methods; D050504:Oncolytic Viruses / Q000235:genetics*; D018139:Simplexvirus / Q000235:genetics*
chemical_list: D020780:Matrix Metalloproteinase 9
references.citation: Mol Ther. 2007 Nov;15(11):1982-90
references.pmid: 17653103
references.citation: Cancer Res. 2005 Dec 1;65(23):10959-69
references.pmid: 16322244
references.citation: PLoS Biol. 2008 Oct 14;6(10):e247
references.pmid: 18922043
references.citation: Science. 2002 Mar 29;295(5564):2387-92
references.pmid: 11923519
references.citation: Cell. 2000 Oct 27;103(3):481-90
references.pmid: 11081634
references.citation: Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24
references.pmid: 17717634
references.citation: Cancer Res. 2006 Mar 1;66(5):2509-13
references.pmid: 16510565
references.citation: J Biol Chem. 2004 May 28;279(22):23151-7
references.pmid: 15047712
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3621-6
references.pmid: 9520415
references.citation: Mol Ther. 2009 Jan;17(1):199-207
references.pmid: 18957964
references.citation: Front Biosci. 1996 Nov 01;1:d324-39
references.pmid: 9159237
references.citation: Mol Ther. 2000 Aug;2(2):114-20
references.pmid: 10947938
references.citation: Cancer Res. 2007 Nov 15;67(22):10664-8
references.pmid: 18006807
references.citation: Mol Cell Biochem. 2003 Nov;253(1-2):269-85
references.pmid: 14619979
references.citation: Cancer Res. 2008 May 1;68(9):3405-12
references.pmid: 18451168
references.citation: Oncogene. 2002 Nov 14;21(52):8011-9
references.pmid: 12439751
references.citation: Clin Cancer Res. 2002 Sep;8(9):2894-901
references.pmid: 12231534
references.citation: Cancer Res. 2000 Dec 15;60(24):6851-5
references.pmid: 11156378